The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users

Journal of Infectious Diseases

Volumn 174, Issue 2, 1996, Pages 299-308

  Manoff, Susan B ^a   Farzadegan, Homayoon ^a   Muñoz, Alvaro ^a   Astemborski, Jacqueline A ^a   Vlahov, David ^a   Rizzo, Rosetta T ^a   Solomon, Liza ^a,b   Graham, Neil M H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Maryland Department of Mental Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; TUBERCULIN; VIRUS RNA;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; TUBERCULIN TEST; TUBERCULOSIS; VIRUS CONCENTRATION;

EID: 0029954426     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.2.299     Document Type: Article

References (9)

1. Raviglione MC, Snider DE Jr, Koch A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-6.
2. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
3. Daley CL, Small PM, Scheeter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med 1992;326:231-5.
4. Flesch IE, Kaufmann SH. Role of cytokines in tuberculosis. Immunobiology 1993;189:316-39.
5. Orme IM. Immunity to mycobacteria. Curr Opin Immunol 1993;5:497-502.
6. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993;262:1011-8.
7. Lederman MM, Georges DL, Kusner DJ, Mudido P, Giam CZ, Toossi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J Acquir Immune Defic Syndr 1994;7:727-33.
8. 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis 1993;167:43-8.
9. Whalen C, Horsburgh CR, Horn D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-35.